Tiziana Life Sciences is trading at $0.69, 10.74% up on November 6, 2026, with no confirmed company-specific catalyst identified for the session’s move.
- Biotech-sector strength may be a backdrop: XBI was up 2.01% during regular trading following positive Moderna earnings.
- Tiziana announced positive Phase 2a results on November 2 and an investor call for November 9; neither is established as the direct cause of today’s gain.